Association between the subsequent benign prostate hyperplasia-related surgery risk and patients treated with Chinese herbal medicine: a population-based Taiwanese cohort study
Ming-Yen Tsai, Chun-Ting Liu, Yu-Sin Shen, Hao-Lun Luo, Tai-Lin Chen, Ying-Hsiu Shih, Yu-Tung Hung, Tzu-Ju Hsu, Fuu-Jen Tsai, Yung-Hsiang Chen · 2026
Read Association between the subsequent benign prostate hyperplasia-related surgery risk and patients treated with Chinese herbal medicine: a population-based Taiwanese cohort study by Ming-Yen Tsai, Chun-Ting Liu, Yu-Sin Shen, Hao-Lun Luo, Tai-Lin Chen, Ying-Hsiu Shih, Yu-Tung Hung, Tzu-Ju Hsu, Fuu-Jen Tsai, Yung-Hsiang Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13321782.txt.
Description
Ming-Yen Tsai and co-authors test if Chinese herbal medicine cuts prostate surgery risk in a 2026 Taiwan cohort study. Enlarged prostate often ends in surgery when drugs fall short. Herbal add-ons are common in Taiwan, but proof was thin and follow-up short. National insurance data give twenty-one years of reach.
Two million beneficiaries seed the sample. Patients newly diagnosed from 2001 to 2016 were matched by health, age, and year. Over eleven thousand herbal users pair with like non-users. Surgery counts over follow-up are nearly tied between groups in the early report. Full hazard models weigh the add-on effect. The scale alone makes the verdict notable.
Catalog record
| CREATOR | Ming-Yen Tsai, Chun-Ting Liu, Yu-Sin Shen, Hao-Lun Luo, Tai-Lin Chen, Ying-Hsiu Shih, Yu-Tung Hung, Tzu-Ju Hsu, Fuu-Jen Tsai, Yung-Hsiang Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |